PubRank

Kenichi A Tanaka

Author PubWeight™ 54.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003 2.31
2 Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. Anesth Analg 2007 2.12
3 Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010 1.87
4 Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2011 1.77
5 The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Anesth Analg 2010 1.48
6 A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. J Am Coll Surg 2005 1.46
7 The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry. Anesth Analg 2014 1.46
8 The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009 1.43
9 Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2011 1.28
10 A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2011 1.07
11 Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology 2008 1.03
12 The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography. Anesth Analg 2005 1.03
13 Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth 2013 0.97
14 Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. J Anesth 2009 0.96
15 Acute aortic dissection with intimal layer prolapse into the left ventricle. Anesth Analg 2007 0.95
16 A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process. Microvasc Res 2011 0.91
17 Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 2013 0.88
18 Electron microscopic evaluations of clot morphology during thrombelastography. Anesth Analg 2004 0.87
19 Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery. Blood Coagul Fibrinolysis 2008 0.85
20 Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma 2010 0.85
21 Perioperative ischemic stroke in non-cardiovascular surgery patients. J Anesth 2010 0.85
22 Evaluation and management of bleeding during cardiac surgery. Curr Hematol Rep 2005 0.85
23 Systemic thromboses after cardiopulmonary bypass: is it thrombin or antithrombin? Anesthesiology 2006 0.84
24 The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry. Anesth Analg 2012 0.83
25 In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma. J Cardiothorac Vasc Anesth 2009 0.82
26 Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry. Platelets 2009 0.82
27 Ensembles of uncertain mathematical models can identify network response to therapeutic interventions. Mol Biosyst 2010 0.82
28 Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth 2010 0.81
29 Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia. Anesth Analg 2007 0.81
30 A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Thromb Haemost 2011 0.80
31 Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion 2013 0.80
32 Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways. J Surg Res 2010 0.80
33 The use of the SonoSite ultrasound device for intraoperative evaluation of the aorta. J Cardiothorac Vasc Anesth 2004 0.80
34 Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors. Blood Coagul Fibrinolysis 2007 0.80
35 Point-of-care coagulation management algorithms during ECMO support: are we there yet? Minerva Anestesiol 2016 0.79
36 The anticoagulated patient: strategies for effective blood loss management. Surgery 2007 0.79
37 Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma. Anesth Analg 2008 0.78
38 Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII. Blood Coagul Fibrinolysis 2008 0.78
39 Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients. J Chromatogr B Analyt Technol Biomed Life Sci 2011 0.78
40 Development of a fast and simple liquid chromatography-tandem mass spectrometry method for the quantitation of argatroban in patient plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci 2012 0.78
41 Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice. Thromb Haemost 2010 0.78
42 Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux. Thromb Res 2010 0.77
43 High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass. J Anesth 2011 0.77
44 Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass. Anesth Analg 2008 0.77
45 A novel method to assess platelet inhibition by eptifibatide with thrombelastograph. Anesth Analg 2004 0.77
46 Clinical applicability of rapid thrombelastography and functional fibrinogen thrombelastography to adult liver transplantation. Liver Transpl 2014 0.77
47 Prohemostatic agents to prevent perioperative blood loss. Semin Thromb Hemost 2008 0.77
48 Fibrinogen measurements in plasma and whole blood: a performance evaluation study of the dry-hematology system. Anesth Analg 2015 0.76
49 Interaction between thrombin mutant W215A/E217A and direct thrombin inhibitor. Blood Coagul Fibrinolysis 2008 0.76
50 Tissue plasminogen activator and thrombin generation measurements using the Thrombinoscope. Blood Coagul Fibrinolysis 2006 0.76
51 Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin. Thromb Res 2009 0.76
52 Management of surgical hemostasis: systemic agents. Vascular 2008 0.76
53 Factor concentrates in trauma. Curr Opin Anaesthesiol 2015 0.76
54 Anticoagulation and reversal paradigms: is too much of a good thing bad? Anesth Analg 2009 0.75
55 Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery? Transfusion 2009 0.75
56 Antiplatelet agents and bleeding after cardiac surgery. Anesth Analg 2004 0.75
57 Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII. J Cardiothorac Vasc Anesth 2010 0.75
58 Impact of Sonoclot hemostasis analysis after cardiopulmonary bypass on postoperative hemorrhage in cardiac surgery. J Anesth 2007 0.75
59 Reduced Requirement for Prothrombin Complex Concentrate for the Restoration of Thrombin Generation in Plasma from Liver Transplant Recipients. Anesth Analg 2017 0.75
60 [The role of physician assistant (PA) in cardiaothoracic surgery at Emory University Hospital]. Nihon Geka Gakkai Zasshi 2010 0.75
61 SEER Sonorheometry: Listening to What the Clot Has to Say. Anesth Analg 2016 0.75
62 Blood component therapy guided by celite-activated thromboelastography for perioperative coagulopathy. J Anesth 2002 0.75
63 In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel. Thromb Res 2013 0.75
64 In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition. Thromb Haemost 2010 0.75
65 The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients. Anesth Analg 2012 0.75
66 Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation. Blood Coagul Fibrinolysis 2008 0.75
67 Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin. Anesthesiology 2008 0.75
68 Prophylactic use of factor IX concentrate in a Jehovah's Witness patient. Ann Thorac Surg 2009 0.75
69 Reassessing RECESS: In Pursuit of the Golden Ratio of Hemostatic Components to Red Blood Cells. Anesth Analg 2017 0.75
70 Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass. Anesth Analg 2016 0.75
71 Acute Intracardiac Thrombosis and Pulmonary Thromboembolism After Cardiopulmonary Bypass: A Systematic Review of Reported Cases. Anesth Analg 2017 0.75
72 Influences of hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model. J Cardiothorac Vasc Anesth 2013 0.75
73 The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery. Anesth Analg 2003 0.75
74 Case Report of Severe Antithrombin Deficiency During Extracorporeal Membrane Oxygenation and Therapeutic Plasma Exchange for Double Lung Transplantation. A A Case Rep 2017 0.75